Sampling for testing with the non-invasive prenatal test NIPT by GenePlanet

NIPT by GenePlanet is an innovative non-invasive prenatal test that offers an early and accurate method for detecting chromosomal abnormalities during pregnancy. The test is intended for women who are at increased risk of giving birth to a child with chromosomal abnormalities such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), Patau syndrome (Trisomy 13), and other genetic disorders. The test is performed in the modern GENEPLANET NGS laboratory based in Zagreb, Croatia, which uses the latest technologies in next-generation sequencing (NGS).

The Medcross Medical Center in Sofia is GenePlanet’s main partner in Bulgaria and provides the service of collecting material for testing. The blood sample required for the test is taken from the mother at specific times – between 11:30 a.m. and 2:00 p.m. on weekdays at 8-10 Stara Planina Street. After the sample is taken, it is sent to the laboratory in Zagreb, where the analysis is performed. The results are sent to the client’s email address within 24 hours.

The entire process of data exchange between Medcross Medical Center and the GenePlanet laboratory is fully digitized, ensuring fast and secure access to information. The test results and detailed report are ready within 6 to 10 business days after the sample is received by the laboratory.

NIPT by GenePlanet is the market leader in Central and Eastern Europe and is present in more than 35 countries worldwide. The test can be performed as early as the 10th week of gestation, making it one of the earliest possible methods for diagnosing chromosomal abnormalities. As a non-invasive method, NIPT is safe for the mother and fetus, with no risk of miscarriage, which is often associated with invasive procedures such as amniocentesis.

One of the main advantages of NIPT by GenePlanet is its precision and comprehensive analysis. The test detects the largest panel of chromosomal abnormalities and has a proven 99% reliability of results. To date, over 10 million NIPT tests have been performed worldwide, highlighting its popularity and trust among expectant parents and medical professionals.